Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$1.90
-0.220 (-10.38%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.81 $2.52 Friday, 10th May 2024 CHRS stock ended at $1.90. This is 10.38% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 20.44% from a day low at $1.81 to a day high of $2.18.
90 days $1.81 $2.87
52 weeks $1.44 $5.63

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Apr 07, 2022 $12.67 $12.89 $12.51 $12.56 369 200
Apr 06, 2022 $12.48 $12.96 $12.48 $12.75 514 400
Apr 05, 2022 $13.25 $13.36 $12.40 $12.59 945 700
Apr 04, 2022 $12.90 $13.39 $12.85 $13.23 511 400
Apr 01, 2022 $12.94 $13.07 $12.48 $12.85 746 104
Mar 31, 2022 $12.84 $13.29 $12.84 $12.91 330 566
Mar 30, 2022 $12.69 $13.46 $12.50 $12.84 736 010
Mar 29, 2022 $12.35 $12.99 $12.05 $12.76 1 193 800
Mar 28, 2022 $12.48 $12.57 $11.72 $11.97 832 800
Mar 25, 2022 $12.82 $12.82 $12.38 $12.43 453 100
Mar 24, 2022 $12.57 $12.92 $12.44 $12.89 476 300
Mar 23, 2022 $12.48 $12.94 $12.45 $12.51 816 100
Mar 22, 2022 $12.19 $12.54 $12.06 $12.43 818 829
Mar 21, 2022 $13.22 $13.31 $12.11 $12.16 817 470
Mar 18, 2022 $12.86 $13.34 $12.75 $13.31 2 044 668
Mar 17, 2022 $12.82 $13.02 $12.57 $12.84 667 800
Mar 16, 2022 $12.63 $12.95 $12.36 $12.89 835 600
Mar 15, 2022 $12.23 $12.94 $11.98 $12.54 876 200
Mar 14, 2022 $12.15 $12.72 $11.96 $12.06 794 800
Mar 11, 2022 $12.58 $12.82 $12.27 $12.33 584 000
Mar 10, 2022 $11.98 $12.59 $11.93 $12.43 765 200
Mar 09, 2022 $11.61 $12.20 $11.60 $12.17 739 000
Mar 08, 2022 $11.62 $11.97 $11.28 $11.44 507 700
Mar 07, 2022 $11.49 $11.85 $11.30 $11.61 631 700
Mar 04, 2022 $11.54 $11.90 $11.54 $11.85 473 800
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT